By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

True North Therapeutics  

951 Gateway Boulevard

South San Francisco  Califonia  94080  U.S.A.
Phone: 650-872-4700 Fax: n/a


SEARCH JOBS




Key Statistics


Email: info@truenorth.com
Ownership: Private

Web Site: True North Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
True North Therapeutics Presents Additional Data From An Ongoing Clinical Study Showing Normalization Of Hemoglobin Levels With TNT009 In Severely Anemic Cold Agglutinin Disease (CAD) Patients 12/5/2016 11:45:59 AM
Tiny Bay Area Biotech True North Therapeutics Bags $45 Million, Bringing the Total to $142 Million 10/18/2016 5:38:49 AM
True North Therapeutics Receives FDA Orphan Drug Designation For TNT009 For The Treatment Of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD) 10/13/2016 12:12:01 PM
True North Therapeutics Appoints Pamela M. Wapnick As Chief Financial Officer 8/2/2016 11:29:47 AM
True North Therapeutics To Present Clinical Data In Patients With Cold Agglutinin Disease (CAD) For Lead Product Candidate TNT009 6/13/2016 10:49:48 AM
True North Therapeutics ’s Lead Product Candidate, TNT009, Demonstrates High Response Rates And Rapid Onset Of Action In Interim Clinical Data In Patients With Cold Agglutinin Disease (CAD) 6/13/2016 10:23:19 AM
True North Therapeutics To Present Clinical Data In Patients With Cold Agglutinin Disease (CAD) For Lead Product Candidate TNT009 5/19/2016 12:21:58 PM
True North Therapeutics Launches COMPASS Registry To Advance Development Of New Therapeutics For Patients With Cold Agglutinin Disease (And Other Autoimmune Hemolytic Anemias) 3/8/2016 9:28:39 AM
True North Therapeutics Receives Orphan Drug Designation In The European Union For TNT009 For The Treatment Of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD) 2/25/2016 9:48:39 AM
Top 20 Life Science Startups to Watch in the U.S. 1/26/2016 7:46:23 AM
123
//-->